DOXGX | LGVAX | DOXGX / LGVAX | |
Total Expense Ratio | 0.41 | 1.01 | 41% |
Annual Report Gross Expense Ratio | 0.46 | 1.04 | 44% |
Fund Existence | 3 years | 16 years | - |
Gain YTD | 3.684 | 0.106 | 3,478% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 3.75B | 3,038% |
Annual Yield % from dividends | 1.49 | 0.80 | 185% |
Returns for 1 year | 6.03 | -3.56 | -169% |
Returns for 3 years | 28.44 | 13.78 | 206% |
Returns for 5 years | N/A | 32.49 | - |
Returns for 10 years | N/A | 46.19 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NRMGX | 18.07 | -0.20 | -1.09% |
Neuberger Berman Mid Cap Growth R6 | |||
JVAAX | 37.23 | -0.45 | -1.19% |
JPMorgan Value Advantage A | |||
HDCVX | 17.28 | -0.24 | -1.37% |
Janus Henderson Responsible Intl Div C | |||
IMOWX | 24.88 | -0.35 | -1.39% |
Voya MidCap Opportunities W | |||
MCMVX | 19.54 | -0.35 | -1.76% |
Monongahela All Cap Value |